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The single-stranded, negative-sense, viral genomic RNA (vRNA) of influenza A virus is
encapsidated by viral nucleoproteins (NPs) and an RNA polymerase to form a ribonucleo-
protein complex (vRNP) with a helical, rod-shaped structure. The vRNP is responsible for
transcription and replication of the vRNA. However, the vRNP conformation during RNA
synthesis is not well understood. Here, using high-speed atomic force microscopy and cryo-
electron microscopy, we investigated the native structure of influenza A vRNPs during RNA
synthesis in vitro. Two distinct types of vRNPs were observed in association with newly
synthesized RNAs: an intact, helical rod-shaped vRNP connected with a folded RNA and a
deformed vRNP associated with a looped RNA. Interestingly, the looped RNA was a double-
stranded RNA, which likely comprises a nascent RNA and the template RNA detached from
NPs of the vRNP. These results suggest that while some vRNPs keep their helical structures
during RNA synthesis, for the repeated cycle of RNA synthesis, others accidentally become
structurally deformed, which likely results in failure to commence or continue RNA synthesis.
Thus, our findings provide the ultrastructural feature of vRNPs during RNA synthesis.
https://doi.org/10.1038/s42003-021-02388-4 OPEN
1 Laboratory of Ultrastructural Virology, Department of Virus Research, Institute for Frontier Life and Medical Sciences, Kyoto University, Kyoto, Japan.
2 Graduate School of Biostudies, Kyoto University, Kyoto, Japan. 3 Hakubi Center for Advanced Research, Kyoto University, Yoshida-honmachi, Sakyo-ku,
Kyoto, Japan. 4Molecular Cryo-Electron Microscopy Unit, Okinawa Institute of Science and Technology Graduate University, Okinawa, Japan. 5 Nano Life
Science Institute (WPI-NanoLSI), Kanazawa University, Kanazawa, Japan. 6 PRESTO, Japan Science and Technology Agency, Kawaguchi, Saitama, Japan.
✉email: t-noda@infront.kyoto-u.ac.jp









Influenza A virus, a member of the Orthomyxoviridae, has eightsingle-stranded, negative-sense RNA (vRNA) segments as itsgenome. Transcription and replication of influenza A virus are
carried out by ribonucleoprotein complexes called vRNPs in the
nucleus of infected cells. A vRNP comprises a vRNA, multiple
copies of nucleoprotein (NP) and a heterotrimeric, RNA-
dependent RNA polymerase complex comprising PB2, PB1 and
PA subunits1–4. Each vRNP adopts a helical, rod-shaped struc-
ture, in which a single strand of a multiple NP–RNA complex is
folded back on itself and coiled, forming a double-stranded helix
with a loop structure at one end5,6. The heterotrimeric RNA
polymerase is located opposite to the loop end of the helical rod-
shaped vRNP7–9.
Although influenza virus vRNPs conduct both transcription
and replication of the vRNAs, mechanisms of the two processes
are quite different. During transcription, the PB2 subunit binds to
the 5′-terminal methylated cap structure (m7GpppXm) of host
pre-mRNAs10,11, and the PA subunit cleaves the pre-mRNA
10–13 nucleotides downstream from the cap with its endonu-
clease activity12–14. The resultant capped RNA fragment is
directed to the PB1 active site where it is used as a primer15. After
elongation, a poly(A) tail is added to the 3′ end of the transcript
by stuttering of the polymerase on the oligo-U stretch of the
template vRNA16–18. Hence, the 5′-capped and 3′-polyadenylated
viral mRNAs are synthesized in a primer-dependent manner. In
contrast, genome replication is thought to be primer-
independent19. Replication involves generation of positive-sense
complementary RNAs (cRNAs), which are replication inter-
mediates that act as templates for vRNA synthesis. Elongation of
a nascent cRNA by cis-acting RNA polymerase proceeds con-
comitantly with sequential binding of free NPs, forming a rod-
shaped, double-helical cRNP complex20–22. Afterward, trans-
acting or trans-activating RNA polymerase generates vRNAs
from intermediate cRNAs21,23,24.
Great progress has been made in delineating the molecular
mechanisms by which the RNA polymerase conducts transcrip-
tion and replication based on its atomic structure15,18,24–30.
However, it is the vRNP rather than the RNA polymerase that
accomplishes viral genome transcription and replication.
Recently, Coloma et al. investigated the structure of the vRNP
during in vitro transcription using cryo-electron microscopy
(cryo-EM) and concluded that the vRNPs maintain their double-
helical structures during transcription31. However, it remains
unclear whether the helical vRNPs they observed are the only
conformation of vRNPs producing nascent RNA. Here, to further
characterize RNA synthesis from an ultrastructural perspective,
we analysed virion-derived vRNPs producing nascent RNAs
during in vitro RNA synthesis, using high-speed atomic force
microscopy (HS-AFM) and cryo-EM. The combination of these
two techniques enabled us to clearly visualize and characterize the
native structures of vRNPs producing nascent RNAs.
Results
Virion-derived vRNPs produce both mRNA and cRNA
in vitro. It has been reported that vRNPs isolated from influenza
virions synthesize both mRNA and cRNA in vitro by adding ApG
or globin mRNA as a primer32. To investigate the structure of
vRNP during RNA synthesis, we purified vRNPs from influenza A/
Puerto Rico/8/34 (PR8) virions and performed in vitro RNA
synthesis using primers in the presence of nucleoside tripho-
sphates. Autoradiography of the RNA products after electrophor-
esis showed bands corresponding to the eight vRNAs of influenza
A virus in a 15-min incubation after the reactions (Fig. 1a, Sup-
plementary Fig. 1a, b). Treatment of an influenza virus RNA
polymerase inhibitor, 6-fluoro-3-hydroxy-2-pyrazinecarboxamide-
4-ribofuranosyl-5′-triphosphate (T-705RTP)33, decreased the band
intensity in a dose-dependent manner (Fig. 1b), confirming that
RNAs are synthesized from virion-derived vRNPs.
Then, to determine whether vRNPs produce both cRNA and
mRNA, we performed strand-specific reverse transcription-
quantitative real-time polymerase chain reaction (RT-qPCR) for
the NP and NA genes34. Although the ApG-primed polyadenylated
RNAs are not capped at the 5′ end, in the present study, we defined
the RNA product as mRNA. Non-specific amplification was barely
detectable (Supplementary Fig. 2a, b). In the absence of the primers,
cRNA and mRNA were hardly detected, except for NP mRNA
(Supplementary Fig. 2c, d). Addition of either ApG or globin
mRNA primer resulted in production of 1 × 105 copies μL−1 to
5 × 106 copies μL−1 of cRNA and mRNA of both NP and NA
segments (Supplementary Fig. 2c, d). These results demonstrated
that virion-derived vRNPs produce both cRNA and mRNA in the
presence of primers. Since there was no significant difference in the
level of RNA production between ApG-primed and globin mRNA-
primed samples, we used ApG as a primer in subsequent
ultrastructural analysis.
During RNA synthesis, vRNPs show two distinctive structures.
Although vRNPs are helical rod-shaped structures in a static
state, it is possible that they may change their conformations
during RNA synthesis. To investigate near-native vRNP struc-
tures producing nascent RNA, we employed HS-AFM, which can
provide topographic images in solution by scanning sample
surfaces with a probe tip, without fixation or staining35. After
in vitro RNA synthesis using primers in the presence of nucleo-
side triphosphates, vRNPs were adsorbed onto a mica substrate
and were visualized in solution. Without the primer, after in vitro
RNA synthesis, vRNPs appeared as rod-shaped structures with
helical grooves (Fig. 1c, Supplementary Fig. 3), which is typical of
vRNP structures visualized by negative-staining EM5. The vRNPs
visualized by HS-AFM showed a right-handed helical structure
(Supplementary Fig. 3). Immediately after adding ApG primer (0
min), vRNPs maintained helical rod-shaped structures (Fig. 1d).
However, after a 15-min incubation with ApG primer, vRNPs
showed distinctive structures that were associated with potentially
nascent RNA. On the basis of their configurations, we classified
vRNP–RNA complexes into two groups: helical rod-shaped
vRNPs associated with a folded RNA (Fig. 1e, f, Supplementary
Fig. 4), and deformed vRNPs associated with a looped RNA
(Fig. 1g, h). The configuration of vRNPs bound to the folded
RNA appeared similar to those of control vRNPs (Fig. 1c). Their
diameters were almost uniform and helical grooves could be
observed along entire rod-shaped vRNPs, suggesting no apparent
conformational changes. Folded RNAs, which appeared to con-
tain some secondary structures, were associated not only with the
tip (Fig. 1e, Supplementary Fig. 4a) but also with the bodies of
helical rod-shaped vRNPs (Fig. 1f, Supplementary Fig. 4b). By
contrast, the configuration of vRNPs associated with looped
RNAs was substantially deformed, such that helical grooves of the
vRNPs had disappeared (Fig. 1g, h). The percentages of helical
vRNPs with folded RNAs and deformed vRNPs with looped
RNAs in all observed vRNPs were 8.40% and 3.63%, respectively
(Supplementary Table 1). vRNPs associated with looped RNA
comprised 30.2% of all vRNP–RNA complexes (N= 96).
To exclude the possibility that vRNPs became physically
deformed after being tapped with the AFM probe tip, we
observed unstained frozen-hydrated samples of vRNP–RNA
complexes using cryo-EM. Both helical rod-shaped vRNPs
associated with folded RNA (Fig. 2a) and deformed vRNPs
associated with looped RNA (Fig. 2b) appeared similar to those
observed with HS-AFM, suggesting that deformation of vRNPs
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occurs during RNA synthesis. To further investigate the
configuration of vRNP–RNA complexes in more detail, we
performed low-dose cryo-electron tomography (cryo-ET) to
analyse their three-dimensional structure. A vRNP without
in vitro RNA synthesis showed a double-helical structure with
several grooves (Fig. 2c), consistent with vRNPs reconstructed by
single-particle cryo-EM7,8,31. The tomographic reconstruction of
a deformed vRNP was able to resolve the continuous RNA loop
associated with the deformed vRNP (Fig. 2d), where both ends of
the loop structure were located relatively close to each other on
the deformed vRNP, suggesting that the viral RNA polymerase
exists at the looped-RNA-binding site, although its structure was
not resolved. Interestingly, we found that the vRNP partially
maintained a double-helical structure at one end, and that only
the portion to which both ends of the looped RNA were bound
was deformed (Fig. 2d), suggesting that deformation of the helical
rod-shaped vRNP likely participates in RNA synthesis. Unfortu-
nately, a folded RNA associated with rod-shaped vRNP could not
be technically reconstructed, because the folded RNAs had a
pleomorphic structure and were not visible enough for cryo-ET
due to the low-contrast images from cryo-EM.
Both folded and looped RNAs associated with vRNPs are viral
RNA products. Next, to determine whether the observed folded
and looped RNAs are products synthesized by vRNPs, we used a
nucleotide analogue, 5-bromo-UTP (Br-UTP), for in vitro RNA
synthesis. When Br-UTP was used for in vitro RNA synthesis
instead of UTP, both folded and looped RNAs associated with
vRNPs were similarly observed (Fig. 3a, b, respectively). Upon
incubation with the antibody, which reacts with Br-UTP present
only in single-stranded RNA, specific binding of the antibody to
the folded RNAs was observed (Fig. 3c, Supplementary Fig. 5),
whereas the antibody did not react with folded RNAs produced
by in vitro RNA synthesis using UTP (Fig. 3e), indicating that the
folded RNAs are single-stranded, nascent RNAs synthesized by
the associated vRNPs. By contrast, the antibody did not bind to
looped RNAs produced during in vitro RNA synthesis using Br-
UTP (Fig. 3d) or UTP (Fig. 3f). Because the looped RNA had no
Fig. 1 HS-AFM observation of vRNPs during RNA synthesis. a Primer-dependent in vitro RNA synthesis using virion-derived vRNPs. RNA was synthesized
in vitro using ApG or globin mRNA as a primer with 30min incubation. As a negative control, the reaction mixture was used without primer. A mixture of
eight influenza A virus vRNA segments (Pols indicates 3 polymerases, PB2, PB1, and PA) transcribed by T7 RNA polymerase was loaded in the leftmost
lane (T7) for evaluation of sizes of the newly synthesized RNAs. b Inhibition of in vitro RNA synthesis by T-705RTP. RNA was synthesized in vitro using
ApG in the presence of the indicated concentration of T-705RTP. All purified RNA samples were analysed on a 4% polyacrylamide gel containing 7M urea
and detected by autoradiography. Uncropped autoradiograph images are shown in Supplementary Fig. 9. c As a negative control for the HS-AFM
observation, the reaction mixture omitting a primer was used. d–h Virion-derived vRNPs were subjected to in vitro RNA synthesis using ApG as a primer.
After incubation for 0min (d) or 15 min (c, e–h), samples were observed with HS-AFM. Folded and looped RNAs associated with the helical (e, f) and
deformed vRNPs (g, h), respectively, were observed as indicated by arrows at the different positions in the same samples. Scale bars on all images
represent 50 nm.
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secondary structure, we presumed that it might be double-
stranded RNA (dsRNA). To test this hypothesis, RNase for
digesting either single-stranded RNA (RNase A) or dsRNA
(RNase III) was added to the looped RNAs and examined in situ
using HS-AFM. With RNase A treatment, one end of the looped
RNA was often detached from the vRNP and became straight;
however, the looped RNA itself was not digested, suggesting that
it is double stranded, except at one end (Fig. 4a, Supplementary
movie 1). By contrast, RNase III digested looped RNAs (Fig. 4b,
Supplementary movie 2). Upon binding, the RNase III molecule
immediately digested the RNA, which was further shortened by
sequential binding of more RNase III molecules, confirming that
the looped RNA was dsRNA. This finding was further verified
using anti-dsRNA antibody. The antibodies efficiently recognized
the looped RNA associated with vRNPs (Fig. 4c, Supplementary
movie 3), while only a few antibody molecules were bound to
parts of the folded RNA, probably through stem-loop regions
within the single-stranded RNA (Fig. 4d, Supplementary
movie 4). We then determined whether influenza viruses generate
dsRNA during RNA synthesis. To address this, Vero cells were
infected with PR8 virus and subjected to immunofluorescence
assay (IFA) using an anti-dsRNA antibody. At 10 h post-infec-
tion, dsRNAs were detected in the nucleus of infected cells
(Fig. 4e). Although the number of dsRNA-positive virus-infected
cells was small (0.16% of infected cells; N= 9153), dsRNA was
not detected in mock-infected cells (Fig. 4e), suggesting that
Fig. 2 Cryo-EM observation of vRNPs during RNA synthesis. An in vitro RNA-synthesis reaction was performed in the presence of ApG, and was
observed with cryo-EM in vitreous ice. Folded RNAs (a, arrows) and looped RNAs (b, arrows) associated with vRNPs were observed. Scale bars represent
50 nm. c, d Cryo-ET analysis of vRNPs during RNA synthesis. c Cryo-ET observations of vRNP without RNA synthesis. d Cryo-ET observations of vRNP
with RNA synthesis. Left panels: Consecutive Z-projections generated from tomograms; Thickness in Z is 44 nm (c) and 88 nm (d). Right panels: 3D
reconstruction of vRNP segmented from the tomograms. The vRNP and RNA are coloured in blue and red, respectively. Scale bars on all images
represent 20 nm.
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influenza viruses produce dsRNA, and that the deformed vRNP
structures associating with the looped RNA might also be pro-
duced in the infected cells.
Next, to determine whether double-stranded, looped RNA
contains nascent RNA, we used 5-ethynyl-UTP (EUTP) for
in vitro RNA synthesis and evaluated its incorporation into
looped RNAs using Click chemistry. A Click reaction with biotin-
azide was followed by incubation with streptavidin, and specific
binding of streptavidin to looped RNAs was confirmed with HS-
AFM (Fig. 5a). However, in the absence of streptavidin
(Supplementary Fig. 6a) or a Click reaction (Supplementary
Fig. 6b), during in vitro RNA synthesis using UTP as a substrate
(Fig. 5b), binding of streptavidin to the looped RNAs was not
observed, suggesting that double-stranded, looped RNAs encom-
pass nascent RNAs produced by associated vRNPs. Taken
together, these results indicate that both folded and double-
stranded, looped RNAs associated with vRNPs are RNA products
formed during in vitro RNA synthesis.
vRNA is partially dissociated from deformed vRNP associated
with looped dsRNA. Given that looped dsRNA contains a single-
stranded, nascent RNA, it is likely that its counterpart is the
template vRNA dissociated from the deformed vRNP during
RNA synthesis. Hence, it is expected that deformed vRNPs have
lower structural stability than intact vRNPs due to loss of its
vRNA as a structural component. To determine whether
deformed vRNPs lose vRNA, at least in part, we examined the
structural stability of vRNPs by applying force with the cantilever
tip during HS-AFM imaging (Fig. 6). Because vRNAs within
vRNPs are sensitive to RNase36, vRNPs treated with a low con-
centration of RNase A were prepared as control vRNPs lacking
intact residential vRNA (Supplementary Fig. 7). Although vRNPs
treated with RNase A maintained their helical rod-shaped
structures, they were easily broken with significantly less force
(Fig. 6a, bottom panel) than untreated vRNPs (Fig. 6a, upper
panel). vRNPs associated with folded RNA were physically stable,
similar to intact vRNPs, whereas vRNPs associated with double-
stranded, looped RNA were broken with significantly less force,
similar to RNase A-treated vRNPs (Fig. 6a, b). Collectively, these
results strongly suggest that at least some parts of template vRNA
are detached from NPs of vRNP during RNA synthesis, resulting
in formation of double-stranded, looped RNA with nascent RNA
and consequent deformation of helical rod-shaped vRNPs.
Discussion
vRNP is responsible for transcription and replication of the
influenza virus genome; however, the details of its structure during
RNA synthesis are not fully understood. Here, we employed HS-
AFM and cryo-EM to visualize near-native vRNP structures during
RNA synthesis. By combining these techniques, we unambiguously
demonstrated that two different types of vRNP–RNA complexes
are produced during ApG-primed RNA synthesis: helical rod-
shaped vRNPs with folded RNA and deformed non-helical vRNPs
with looped dsRNA. Our results suggest that some vRNPs likely
maintain their helical structures for repetitive transcription and/or
replication; however, other vRNPs likely fail repetitive RNA
synthesis due to deformation of their helical structures.
During in vitro RNA synthesis using the ApG primer, RT-qPCR
confirmed that vRNPs produce not only cRNA but also poly-
adenylated mRNA (Supplementary Fig. 2), although a previous
study reported no detection of apparent mRNA production from
vRNPs using a primer-extension assay32. This discrepancy could
be the methodology employed, as RT-qPCR detects polyadenyla-
tion of RNA products at the 3′ end with relatively high sensitivity,
whereas primer-extension assays detect the addition of ApG
nucleotides to the 5′ end of the RNA products. Production of
Fig. 3 Incorporation of Br-UTP into newly synthesized RNAs. a–d Br-UTP was used for in vitro RNA synthesis instead of UTP and HS-AFM images were
taken without (a, b) or with (c, d) adding an antibody against Br-UTP. Binding of anti-Br-UTP antibodies was confirmed on folded RNAs (c, arrows) while
no binding was observed on looped RNAs (d). Section analysis of the image (c) is shown in Supplementary Fig. 5. e, f vRNPs were in vitro transcribed using
UTP and anti-Br-UTP antibody was added to the mixture. Each of these results was reproduced at least three times. Scale bars, 50 nm.
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polyadenylated RNA by in vitro RNA synthesis using the ApG
primer can also be confirmed by using purified RNA polymerase37.
Additionally, we confirmed that ApG-primed productions of
cRNA and mRNA were at similar levels to those primed by globin
mRNA (Supplementary Fig. 2). Taken together, these findings
suggest that virion-derived vRNPs are able to produce both cRNA
and mRNA by ApG priming.
One of the largest advantages of using HS-AFM is that it allows
visualization of dynamic processes of biological molecules under
physiological conditions35. To record RNA synthesis of vRNP by
HS-AFM, we performed in vitro RNA-synthesis reactions on
mica under various conditions; however, vRNPs on the mica
substrate did not produce RNA. For HS-AFM observation,
samples must be attached on a flat substrate, which often leads to
the loss of sample flexibility. Therefore, we speculated that the
vRNPs adsorbed on mica cannot change their helical conforma-
tion, which would structurally hinder movement of that viral
polymerase on the vRNP. In line with this notion, a recent report
by Coloma et al.31 showed that vRNPs cannot produce RNA by
ApG priming, when treated with nucleozin, which directly binds
NPs and blocks vRNP flexibility. Thus, in the present study, we
showed ultrastructures of the vRNPs after in vitro RNA synthesis
in a microcentrifuge tube.
We found that vRNP synthesizing folded RNA was not greatly
deformed and maintained its helical rod-shaped structure
(Fig. 1e, f). The helical, rod-shaped configuration of vRNP asso-
ciated with folded RNA was highly similar to that of vRNPs in a
static state. However, we speculated that these two structures are
essentially different. In vRNPs in a static state, the RNA poly-
merase complex exists at the tip of the helical, rod-shaped
vRNP7–9, whereas in vRNPs that synthesize folded RNA, locali-
zation of the RNA polymerase is likely not limited to the tip of the
helical, rod-shaped vRNP, given that the folded RNA was not
only associated with the tip but also with the body of the rod-
shaped vRNP (Fig. 1, Supplementary Fig. 4). In support of this
observation, Coloma et al.31 recently reported localization of
RNA polymerase on the body of helical, rod-shaped vRNP during
transcription. Although the nascent RNA structures in their cryo-
EM images were not well resolved, the vRNPs observed in that
study likely correspond to the vRNPs producing folded RNAs in
the present study.
Although we could not determine whether folded RNA asso-
ciated with the helical vRNPs was mRNA or cRNA, the vRNPs
with folded RNA are consistent with the progressive helical track-
transcription model proposed by Coloma et al.31. Therefore, we
propose that helical vRNPs with folded RNA represent the correct
Fig. 4 Production of a double-stranded RNA by vRNP. a, b Digestion of looped RNAs with RNases. During HS-AFM observation of looped RNA associated
with vRNP, RNase A (a) or RNase III (b) was added to the liquid chamber at a final concentration of 0.5 μgmL−1 or 0.02 U μL−1, respectively. Five images
were arbitrarily selected from each movie at the indicated times. One end of the looped RNA was detached from vRNP by adding RNase A at the position
indicated by arrows (a). By contrast, RNase III digested looped RNA where the RNase bound (b, arrows). Scale bars represent 100 nm. c, d Binding of anti-
dsRNA antibodies to RNA associated with the vRNP. Antibodies bound to looped RNA (c) and to folded RNA (d) are indicated by arrows. Results were
reproduced at least five times. Scale bars in c, d represent 50 nm. e Detection of dsRNA in virus-infected cells by IFA. Vero cells were infected with
influenza virus PR8 strain at MOI of 1. Infected cells were fixed at 10 h post-infection and double-stained with anti-NP and anti-dsRNA antibodies. Cell
nuclei were stained with Hoechst. Scale bars, 20 μm.
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RNA-synthesis mode, because maintenance of the helical, rod-
shaped vRNP structure is favourable to commencing the next
round of RNA synthesis (Fig. 7). Assuming that the folded RNA
is an mRNA, the 5′-terminus of vRNA is associated with RNA
polymerase throughout transcription25,37. If the 3′ end of vRNA
is released from the RNA polymerase during this process, the
helical structure of the vRNP would be largely loosened (Sup-
plementary Fig. 8, pattern A). However, such a loosened vRNP
structure has never been observed, suggesting that the 3′ end of
the vRNA is not detached, which is consistent with a recent
finding that the 3′ end of vRNA binds to the secondary binding
site of RNA polymerase after transcription18. Therefore, vRNPs
associated with folded RNA would represent engagement in
transcription (Supplementary Fig. 8, pattern B), as reported by
Coloma et al.31.
By contrast, the vRNP structure associated with the looped
RNA was largely deformed into non-helical structures, likely
because the vRNA is at least partially detached from the NPs of
the vRNP (Figs. 1, 2). We speculated that the deformed vRNPs
associated with looped RNA would be unable to proceed to
subsequent rounds of RNA synthesis for the following reasons.
First, the looped dsRNA must be unwound; however, such heli-
case activity has not been reported for influenza virus polymerase.
Second, the template vRNA should re-bind to the NPs of the
vRNP, and the deformed vRNP must be refolded into its native
double-helical structure. Considering these complicated events, it
is reasonable to presume that deformed vRNPs associated with
looped RNA represent a failure of RNA synthesis (Fig. 7). If
deformation of vRNPs sometimes occurs in virus-infected cells,
some vRNPs would fail to produce nascent RNAs and the
encoded viral proteins, whereas other vRNPs could be successful
in RNA synthesis. Indeed, when influenza viruses infect at a low
multiplicity of infection (MOI), one or more viral proteins are not
expressed in some cells38,39. Although further studies are required
to determine whether the deformed vRNP is indeed produced in
virus-infected cells, deformation of vRNPs during RNA synthesis
might be related to such observations.
Interestingly, looped RNAs associated with deformed vRNPs
were dsRNAs, which likely comprise nascent RNA and template
vRNA (Figs. 3–6). Because we performed in vitro RNA synthesis
Fig. 5 incorporation of EUTP into looped RNA. a Confirmation of the
incorporation of EUTP into looped RNA using Click chemistry. Streptavidin
molecules binding to looped RNA are indicated by arrows. b Negative
control of the Click reaction. The sample was prepared using UTP instead of
EUTP. Each of these results was reproduced at least three times. Scale
bars, 50 nm.
Fig. 6 Deformation of vRNP by releasing the residential vRNA. a Deformation of vRNPs with the AFM probe tip. vRNP without a nascent RNA, with a
folded RNA or with a looped RNA was deformed by applying force with the cantilever tip during the HS-AFM observation. As a control for the vRNP lacking
its intact vRNA, the vRNP pre-treated with 0.05 μg mL−1 of RNase A was also deformed. When the vRNP was confirmed as deformed (arrows), the force
was measured as described in the Methods. Image sets are representative of 5 vRNPs of each sample and average forces required for deforming vRNPs are
calculated. b Structural stability of vRNP during RNA synthesis. The force required for deforming the vRNP without nascent RNA was set as 100% and the
relative force of each sample is shown. Significance was determined using the Tukey-Kramer multiple comparison test in R software. P < 0.05 was
considered statistically significant. Error bars represent the standard deviation of five independent measurements.
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in the absence of free NP, free RNA polymerase, and host factors,
such as ANP32A40, all of which are required for vRNA replica-
tion and vRNP formation, the looped dsRNA might represent an
aberrant product of vRNA replication. Although ~3.6% of ApG-
primed vRNPs produced looped dsRNA in vitro, dsRNAs were
detected in only 0.16% of virus-infected cells (Fig. 4e), suggesting
that such host factors and/or viral proteins would prevent dsRNA
formation in virus-infected cells. Although further analysis is
needed, this finding suggests that looped dsRNAs observed
in vitro might be accidentally produced in virus-infected cells.
Measurement of structural stability via the cantilever tip of HS-
AFM showed a lower stability of deformed vRNP with looped
dsRNA, likely due to the detachment of template vRNA from NPs
of vRNPs (Fig. 6). Because the stability of helical vRNPs would be
compromised not only by loss of vRNA but also distortion of the
helical structure, we cannot exclude the possibility that helical-
structure distortion might contribute to the lower stability
observed in the deformed vRNPs. However, given that the dsRNA
contains newly synthesized progeny RNA (Fig. 5), the dsRNA
must comprise the template vRNA complementary to the pro-
geny RNA. Thus, we speculated that the lower stability of
deformed vRNPs was caused by vRNA detachment from
the vRNPs.
In conclusion, by combining HS-AFM and cryo-EM, we
identified two morphologically distinct vRNPs during RNA
synthesis. Our results suggest that helical structures are pre-
requisite for successful repetitive RNA synthesis, whereas defor-
mation of helical structures would represent abortive RNA
synthesis. There remain numerous unresolved questions. Future
investigations should attempt to identify the determinants of
looped-RNA formation and folded-RNA synthesis by adding
related proteins during in vitro RNA synthesis, given that the
in vitro RNA-synthesis approach described here lacks the host
factors and viral NPs necessary for the generation of progeny
vRNPs. These findings provide novel insights into RNA synthesis
along with strong evidence regarding the composition and
mechanism of production of viral RNAs.
Methods
Purification of vRNP. Influenza A virus, A/Puerto Rico/8/34 (H1N1) (PR8), was
prepared, as previously reported9. Purified PR8 virions (~5 mgmL−1) were lysed in
50 mM Tris-HCl buffer (pH 8.0) containing 100 mM KCl, 5 mM MgCl2, 1 mM
dithiothreitol (DTT), 2% Triton X-100, 5% glycerol, 2% lysolecithin and 1 U μL−1
RNasin Plus RNase inhibitor (Promega, Madison, WI, USA) for 1 h at 30 °C. The
sample was ultracentrifuged through a 30–70% (w/v) glycerol gradient in Tris-
NaCl buffer [50 mM Tris-HCl (pH 8.0) and 150 mM NaCl] at 45,000 rpm for 3 h at
4 °C in a SW55Ti rotor (Beckman Coulter, Brea, CA, USA). Collected fractions
were mixed with 2× Tris-glycine SDS sample buffer (Novex; Invitrogen, Carlsbad,
CA, USA) and then subjected to SDS-PAGE using a 4–15% Mini Protean TGX
precast gel (Bio-Rad Laboratories, Hercules, CA, USA).
In vitro RNA synthesis using virion-derived RNPs. Purified vRNP (1–2mgmL−1
for cryo-EM and 0.01mgmL−1 for other experiments) was incubated in 50mM Tris-
HCl buffer (pH 7.9) containing 5mM MgCl2, 40mM KCl, 1mM DTT, 10 μgmL−1
actinomycin D, 1 mM each of ATP, CTP, GTP and UTP, 1 U μL−1 RNasin Plus
RNase inhibitor with a primer, and 1mM ApG (IBA Lifesciences, Göttingen, Ger-
many). In some experiments, 10 μgmL−1 rabbit globin mRNA (Sigma–Aldrich, St.
Louis, MO, USA) was used as a primer instead of ApG. The reaction was performed
at 30 °C for 15min (for ApG primer) or 30min (for globin mRNA primer) unless
otherwise noted. For detection of newly synthesized RNA by radioisotope, the same
reaction mixture was used with the exception that 0.25 μCi μL−1 [α-32P] UTP and
0.05mM UTP were added. After in vitro RNA synthesis, RNA was purified with an
RNeasy Mini kit (Qiagen, Hilden, Germany), mixed with an equal volume of 2× RNA
loading dye (New England Biolabs, Ipswich, MA, USA), heated at 90 °C for 2 min,
and immediately chilled on ice. The sample was electrophoresed on a 4% poly-
acrylamide gel containing 7M urea in 0.5× TBE buffer (Nacalai Tesque, Kyoto, Japan)
at 120 V for 5 h. The gel was dried at 80 °C for 2 h, exposed to an imaging plate (BAS-
MS 2025; Fujifilm, Tokyo, Japan) for 12 h to 24 h, and scanned with a Typhoon 3000
Phosphorimager (GE Healthcare, Chicago, IL, USA). Labelling of nascent RNA with a
nucleotide analogue was also performed in the same reaction mixture using 1mM Br-
UTP (Sigma–Aldrich) or 1mM EUTP (Abcam, Cambridge, UK) instead of UTP.
Inhibition of RNA synthesis was evaluated by adding 0.1–100 μM of 6-fluoro-3-
hydroxy-2-pyrazinecarboxamide-4-ribofuranosyl-5′-triphosphate (T-705RTP; kindly
provided by Furuta Y., Fujifilm Toyama Chemical Co., Ltd.) to the reaction mixture.
Preparation of viral RNA with T7 RNA polymerase. RNA standards for NP and
NA segments of PR8 virus were prepared, as described previously34. Templates
containing a T7 phage promoter sequence (TAATACGACTCACTATAGGG) were
amplified by PCR using sets of primers listed in Supplementary Table 2 and the
pPolI plasmid harbouring the sequence of each segment41. PCR products were
purified with a Min Elute gel extraction kit (Qiagen) and transcribed in vitro with
RiboMAX large-scale RNA production sysytem-T7 (Promega) according to man-
ufacturer instructions. After RQ1 DNase I (Promega) treatment for 30 min at
37 °C, transcripts were purified using an RNeasy mini kit. The concentration of
purified RNA was determined by spectrophotometry, and the copy number was
calculated from the molecular weight of each RNA. RNA (1 × 1010 copies) was then
subjected to electrophoresis on a 4% polyacrylamide gel containing 7M urea and
visualized with silver staining using a Silver Staining II kit (Wako Pure Chemical
Industries, Ltd., Osaka, Japan). Additionally, all eight vRNA segments of influenza
A virus (A/WSN/33 strain) were similarly prepared and used as markers for
electrophoresis. Template DNAs were amplified with the primers listed in Sup-
plementary Table 3 and transcribed by T7 RNA polymerase using 0.25 μCi μL−1
[α-32P] UTP. Transcribed RNAs were purified and mixed before electrophoresis.
RT-qPCR. RT-qPCR was performed as described by Kawakami et al.34. The RNA
standard or in vitro transcribed RNA was mixed with a quarter volume of 10 μM
tagged primer (sequence is provided in Supplementary Table 4) and incubated at
65 °C for 10 min. After immediately chilling on ice for 5 min, the mixture was pre-
heated at 60 °C for 5 min, and then three volumes of the reaction mixture [final
concentration: 1× First Strand buffer (Invitrogen), 5 mM DTT, 0.5 mM each dNTP
mix, 10 U μL−1 Superscript III reverse transcriptase (Invitrogen), and 1 U μL−1
RNasin Plus RNase inhibitor prepared with saturated trehalose and pre-heated at
60 °C for 5 min] were added to the RNA solution at 60 °C, and the mixture was
further incubated for 1 h at 60 °C. The reaction was stopped by heating at 85 °C for
5 min, and the cDNA solution was stored on ice until use. cDNA solution (diluted
1:50) was mixed with forward and reverse qPCR primers (each at a final con-
centration of 1 μM; sequences given in Supplementary Table 4), to which an equal
volume of Thunderbird SYBR qPCR mix (Toyobo, Osaka, Japan) was added. The
qPCR reaction was performed on a Rotor-Gene Q system (Qiagen) using the
following conditions: 95 °C for 1 min, followed by 40 cycles of 95 °C for 15 s and
60 °C for 30 s. For absolute quantitation, 10-fold serial dilutions (1 × 109–1 × 104
copies μL−1) of synthetic RNA standards prepared as described were used to
generate a standard curve. The copy number was calculated from the standard
curve with a strong linear correlation (R2 > 0.99) and amplification efficiency
between 95 and 105%. The detection limit was 1 × 104 copies μL−1.
HS-AFM. In vitro RNA synthesis was performed in a microcentrifuge tube, with
2 µL of sample dropped onto freshly cleaved mica without surface modification.
After incubation for the desired time (~1–5min) at room temperature, the mica
surface was then washed sufficiently with imaging buffer [50mM Tris-HCl (pH 7.9),
5 mM MgCl2, 40mM KCl and 1mM DTT] and immersed in a liquid chamber filled
with 80 µL of the imaging buffer for observation at room temperature using an HS-
AFM system (Nano Explorer; Research Institute of Biomolecule Metrology Co., Ltd.,
Ibaraki, Japan). We performed HS-AFM in tapping mode, in which the cantilever
was excited to oscillate at its resonant frequency in the vertical direction during
lateral and vertical scanning of the cantilever chip in order to allow the tip to
Fig. 7 Model for synthesis of nascent viral RNAs by influenza vRNPs.
When folded viral RNA is synthesized, the vRNP keeps its helical rod-
shaped structure and the vRNP is used in next round of RNA synthesis
(upper). In contrast, when looped dsRNA is produced, the vRNP disrupts its
helical rod-shaped structure because it loses the residential vRNA. As a
result, such deformed vRNP cannot proceed to the next round of RNA-
synthesis cycle (lower).
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intermittently tap the sample surface. Images were collected at two images s−1 using
cantilevers with a 0.1 Nm−1 spring constant and a resonance frequency in water of
0.6MHz (BL-AC10DS; Olympus, Tokyo, Japan). To acquire high-resolution images,
the electron-beam-deposited tips were fabricated using phenol or ferrocene powder,
as described by Uchihashi et al.42. Incorporation of Br-UTP into nascent RNA was
confirmed by incubating in vitro transcripts with 0.1 mgmL−1 monoclonal anti-5-
bromodeoxyuridine antibody (SAB4700630; Sigma–Aldrich) for 2 h at 4 °C in a
microcentrifuge tube and imaging the sample with HS-AFM. Production of the
dsRNA was examined by adding 1 μgmL−1 J2 antibody (10010200; Scicons; Nordic-
MUbio, Susteren, The Netherlands) to the reaction mixture in a microcentrifuge
tube, incubating for 2 h at 4 °C, and observing it by HS-AFM. In situ observation of
RNA digestion by each RNase was performed by adding a 10% volume of the
indicated concentration of RNase A (Epicentre; Illumina, San Diego, CA, USA) or
ShortCut RNase III (New England Biolabs) to the AFM liquid cell during imaging.
At least five independent experiments were performed for each RNase, and all HS-
AFM images were viewed and analysed with Kodec 4.4.7.3943. A low-pass filter and a
flattening filter were applied to individual images to remove spike noise and flatten
xy-plane, respectively.
Cryo-EM. vRNP reaction solution (1 µL) was applied to a glow-discharged holey
carbon grid (Quantifoil R1.2/1.3, Cu 300 mesh; Quantifoil, Jena, Germany) and
blotted manually, followed by application of 2 μL of reaction solution, blotting and
rapid freezing in liquid ethane on a Vitrobot Mark IV system (Thermo Fisher
Scientific, Waltham, MA, USA). Images were recorded close to focus with a Volta
phase plate on a Talos Arctica electron microscope equipped with a Falcon III
camera (Thermo Fisher Scientific) in integrating mode. The total dose during a
single exposure was ~40 electrons/Å2.
For cryo-ET, 2 μL of vRNP reaction solution mixed with colloidal gold (1.9- or
5-nm diameter) were applied to glow-discharged holey carbon grids (C-Flat CF-
MH-2C; Protochips Inc., Morrisville, NC, USA) and rapidly frozen in liquid ethane
on a Vitrobot Mark IV (Thermo Fisher Scientific). Images were recorded on a
Titan Krios electron microscope equipped with a Falcon II camera (Thermo Fisher
Scientific). Tilt series were acquired from −60° to 60° with 2° steps using the
Leginon System44. The total dose during a single-tilt series was 120 electrons/Å2.
Tilt-series data were processed in IMOD45 by using gold particles as fiducial
markers for manual image registration after 2× binning (final voxel size: 4.4 Å3). A
tomogram of the entire field of view was reconstructed using Simultaneous
Iterative Reconstruction Technique. Volumes of interest were extracted from the
reconstructed 3D tomogram and visualized with IMOD and AMIRA 6.1 (Thermo
Fisher Scientific). Consecutive Z-projections were generated using ImageJ46.
Modification of RNA using Click chemistry. A Click-iT RNA imaging kit was
purchased from Invitrogen. After in vitro RNA synthesis with EUTP, the sample
was deposited on mica and incubated for 3 min at room temperature. The mica
surface was then washed with imaging buffer, and the following reactions were all
performed on mica without drying the surface. Imaging buffer on the mica surface
was replaced with Click-iT reaction cocktail [Click-iT RNA reaction buffer con-
taining 4 mM CuSO4, 0.02 mgmL−1 biotin-azide (Thermo Fisher Scientific), and
0.1× Click-iT reaction buffer additive] and incubated for 30 min under light
shielding. The mica surface was then washed with imaging buffer, and the buffer
was replaced with 0.1 mgmL−1 of streptavidin solution (Jackson ImmunoResearch,
West Grove, PA, USA). After 15 min of incubation at room temperature, the mica
surface was washed again with imaging buffer for the HS-AFM observation.
IFA. Vero cells (CCL-81; ATCC, Manassas, VA, USA) were grown in Eagle’s mini-
mum essential medium (MEM) and seeded on 35-mm glass-bottom dish (Matsunami
Glass, Osaka, Japan) coated with rat collagen I (Corning, Corning, NY, USA) 1 day
before infection. Cells were infected with PR8 virus at an MOI of 0.1 and incubated for
10 h in MEM (Gibco, Gaithersburg, MD, USA) containing 0.3% BSA. Infected cells
were fixed in 4% paraformaldehyde (Nacalai Tesque) for 10min and permeabilized
with 0.1% Triton X-100 in PBS for 10min. Cells were then washed with PBS and
blocked with Blocking One (Nacalai Tesque) for 30min. After blocking, cells were
incubated with anti-NP rabbit polyclonal (1:1000 dilution, GTX125989; GeneTex,
Irvine, CA, USA) and anti-dsRNA mouse monoclonal antibody J2 (1:500 dilution,
10010200; Scicons) overnight at 4 °C. Cells were then washed with PBS and incubated
with Alexa Fluoro 488-conjugated anti-mouse antibody (1:2000 dilution, A11001;
Thermo Fisher Scientific) and Hoechst 33342 (Thermo Fisher Scientific) for 1 h at 4 °
C. After incubation, cells were washed with PBS and incubated with Alexa Fluoro 555-
conjugated anti-rabbit antibody (1:1000 dilution, A21428; Thermo Fisher Scientific)
for 1 h at room temperature. All antibodies were diluted in PBS with 10% Blocking
One. Section images were recorded and deconvolved using DeltaVision Elite system
(GE Healthcare) with a ×60 oil immersion objective on an Olympus IX71 microscope.
Force measurement by HS-AFM. To measure the force applied to the sample
surface, two types of HS-AFM images were obtained simultaneously: topographic
images and amplitude images. By measuring the thermal noise and the inverse
optical lever sensitivity (InvOLS) value [nm V−1] of the deflection signal of a
cantilever, we determined the spring constant (kc) [pN nm−1] and quality factor
(Qc) of the cantilever, as described previously47. Determined kc values were in good
agreement with nominal values reported by the manufacturer. During observation,
the vRNP was destroyed by gradually lowering the set point. Destruction of the
vRNP was determined from the apparent change in the height of the vRNP. After
imaging, the amplitude value [V] at the frame in which the vRNP was destroyed was
measured from the amplitude image, and the obtained value was converted into Asp
[nm] using the InvOLS value. The free cantilever-oscillation amplitude A0 was
measured by releasing the cantilever from the sample surface. The average
tip–sample-interaction force <Ft> was calculated using the following equation:
<Fts>= kc (A02−Asp2)1/2/ Qc48. For preparation of control vRNP, we treated 0.01
mgmL−1 of vRNP with 0.05 μg mL−1 of RNase A for 10min at 37 °C. Degradation
of the vRNA was confirmed by RT-PCR using primers used to detect the full-length
NP segment.
Statistics and reproducibility. All statistical analyses were performed using
available R packages (https://www.r-project.org/). P-value of <0.05 was considered
statistically significant. All experiments performed on the paper were successfully
replicated more than three times.
Reporting summary. Further information on research design is available in the Nature
Research Reporting Summary linked to this article.
Data availability
All data supporting the findings of this study are available within the paper or
Supplementary information files, or are available from the corresponding author upon
reasonable request.
Received: 1 February 2021; Accepted: 23 June 2021;
References
1. Eisfeld, A. J., Neumann, G. & Kawaoka, Y. At the centre: influenza A virus
ribonucleoproteins. Nat. Rev. Microbiol. 13, 28–41 (2015).
2. Ortin, J. & Martin-Benito, J. The RNA synthesis machinery of negative-
stranded RNA viruses. Virology 479–480, 532–544 (2015).
3. te Velthuis, A. J. & Fodor, E. Influenza virus RNA polymerase: insights
into the mechanisms of viral RNA synthesis. Nat. Rev. Microbiol. 14, 479–493
(2016).
4. Pflug, A., Lukarska, M., Resa-Infante, P., Reich, S. & Cusack, S. Structural
insights into RNA synthesis by the influenza virus transcription-replication
machine. Virus Res. 234, 103–117 (2017).
5. Compans, R. W., Content, J. & Duesberg, P. H. Structure of the
ribonucleoprotein of influenza virus. J. Virol. 10, 795–800 (1972).
6. Jennings, P. A., Finch, J. T., Winter, G. & Robertson, J. S. Does the higher
order structure of the influenza virus ribonucleoprotein guide sequence
rearrangements in influenza viral RNA? Cell 34, 619–627 (1983).
7. Moeller, A., Kirchdoerfer, R. N., Potter, C. S., Carragher, B. & Wilson, I. A.
Organization of the influenza virus replication machinery. Science 338,
1631–1634 (2012).
8. Arranz, R. et al. The structure of native influenza virion ribonucleoproteins.
Science 338, 1634–1637 (2012).
9. Sugita, Y., Sagara, H., Noda, T. & Kawaoka, Y. Configuration of viral
ribonucleoprotein complexes within the influenza A virion. J. Virol. 87,
12879–12884 (2013).
10. Blaas, D., Patzelt, E. & Kuechler, E. Identification of the cap binding protein of
influenza virus. Nucleic Acids Res. 10, 4803–4812 (1982).
11. Guilligay, D. et al. The structural basis for cap binding by influenza virus
polymerase subunit PB2. Nat. Struct. Mol. Biol. 15, 500–506 (2008).
12. Plotch, S. J., Bouloy, M., Ulmanen, I. & Krug, R. M. A unique cap(m7GpppXm)-
dependent influenza virion endonuclease cleaves capped RNAs to generate the
primers that initiate viral RNA transcription. Cell 23, 847–858 (1981).
13. Yuan, P. et al. Crystal structure of an avian influenza polymerase PA(N)
reveals an endonuclease active site. Nature 458, 909–913 (2009).
14. Dias, A. et al. The cap-snatching endonuclease of influenza virus polymerase
resides in the PA subunit. Nature 458, 914–918 (2009).
15. Reich, S. et al. Structural insight into cap-snatching and RNA synthesis by
influenza polymerase. Nature 516, 361–366 (2014).
16. Robertson, J. S., Schubert, M. & Lazzarini, R. A. Polyadenylation sites for
influenza virus mRNA. J. Virol. 38, 157–163 (1981).
17. Poon, L. L., Pritlove, D. C., Sharps, J. & Brownlee, G. G. The RNA polymerase
of influenza virus, bound to the 5′ end of virion RNA, acts in cis to
polyadenylate mRNA. J. Virol. 72, 8214–8219 (1998).
18. Wandzik, J. M. et al. A structure-based model for the complete transcription
cycle of influenza polymerase. Cell 181, 877–893 (2020).
19. Hay, A. J., Skehel, J. J. & McCauley, J. Characterization of influenza virus RNA
complete transcripts. Virology 116, 517–522 (1982).
COMMUNICATIONS BIOLOGY | https://doi.org/10.1038/s42003-021-02388-4 ARTICLE
COMMUNICATIONS BIOLOGY |           (2021) 4:858 | https://doi.org/10.1038/s42003-021-02388-4 | www.nature.com/commsbio 9
20. Honda, A., Ueda, K., Nagata, K. & Ishihama, A. RNA polymerase of influenza
virus: Role of NP in RNA chain elongation. J. Biochem. 104, 1021–1026 (1988).
21. York, A., Hengrung, N., Vreede, F. T., Huiskonen, J. T. & Fodor, E. Isolation and
characterization of the positive-sense replicative intermediate of a negative-
strand RNA virus. Proc. Natl Acad. Sci. USA 110, E4238–E4245 (2013).
22. Turrell, L., Lyall, J. W., Tiley, L. S., Fodor, E. & Vreede, F. T. The role and
assembly mechanism of nucleoprotein in influenza A virus ribonucleoprotein
complexes. Nat. Commun. 4, 1591 (2013).
23. Jorba, N., Coloma, R. & Ortin, J. Genetic trans-complementation establishes a
new model for influenza virus RNA transcription and replication. PLoS
Pathog. 5, e1000462 (2009).
24. Fan, H. et al. Structures of influenza A virus RNA polymerase offer insight
into viral genome replication. Nature 573, 287–290 (2019).
25. Pflug, A., Guilligay, D., Reich, S. & Cusack, S. Structure of influenza A
polymerase bound to the viral RNA promoter. Nature 516, 355–360 (2014).
26. Hengrung, N. et al. Crystal structure of the RNA-dependent RNA polymerase
from influenza C virus. Nature 527, 114–117 (2015).
27. Lukarska, M. et al. Structural basis of an essential interaction between
influenza polymerase and Pol II CTD. Nature 541, 117–121 (2018).
28. Serna Martin, I. et al. A mechanism for the activation of the influenza virus
transcriptase. Mol. Cell 70, 1101–1110 (2018).
29. Kouba, T., Drncova, P. & Cusack, S. Structural snapshots of actively
transcribing influenza polymerase. Nat. Struct. Mol. Biol. 26, 460–470 (2019).
30. Peng, Q. et al. Structural insight into RNA synthesis by influenza D
polymerase. Nat. Microbiol. 4, 1750–1759 (2019).
31. Coloma, R. et al. Structural insights into influenza A virus ribonucleoproteins
reveal a processive helical track as transcription mechanism. Nat. Microbiol. 5,
727–734 (2020).
32. Vreede, F. T. & Brownlee, G. G. Influenza virion-derived viral
ribonucleoproteins synthesize both mRNA and cRNA in vitro. J. Virol. 81,
2196–2204 (2007).
33. Furuta, Y. et al. Favipiravir (T-705), a novel viral RNA polymerase inhibitor.
Antivir. Res. 100, 446–454 (2013).
34. Kawakami, E. et al. Strand-specific real-time RT-PCR for distinguishing
influenza vRNA, cRNA, and mRNA. J. Virol. Methods 173, 1–6 (2011).
35. Ando, T. High-speed atomic force microscopy. Curr. Opin. Chem. Biol. 51,
105–112 (2019).
36. Baudin, F., Bach, C., Cusack, S. & Ruigrok, R. W. Structure of influenza virus
RNP. I. Influenza virus nucleoprotein melts secondary structure in panhandle
RNA and exposes the bases to the solvent. EMBO J. 13, 3158–3165 (1994).
37. Pritlove, D. C., Poon, L. L., Fodor, E., Sharps, J. & Brownlee, G. G.
Polyadenylation of influenza virus mRNA transcribed in vitro from model
virion RNA templates: requirement for 5′ conserved sequences. J. Virol. 72,
1280–1286 (1998).
38. Martin, K. & Helenius, A. Nuclear transport of influenza virus
ribonucleoproteins: the viral matrix protein (M1) promotes export and
inhibits import. Cell 67, 117–130 (1991).
39. Brooke, C. B. et al. Most influenza a virions fail to express at least one essential
viral protein. J. Virol. 87, 3155–3162 (2013).
40. Carrique, L. et al. Host ANP32A mediates the assembly of the influenza virus
replicase. Nature 587, 638–643 (2020).
41. Neumann, G. et al. Generation of influenza A viruses entirely from cloned
cDNAs. Proc. Natl Acad. Sci. USA 96, 9345–9350 (1999).
42. Uchihashi, T., Kodera, N. & Ando, T. Guide to video recording of structure
dynamics and dynamic processes of proteins by high-speed atomic force
microscopy. Nat. Protoc. 7, 1193–1206 (2012).
43. Ngo, K. X., Kodera, N., Katayama, E., Ando, T. & Uyeda, T. Q. Cofilin-
induced unidirectional cooperative conformational changes in actin filaments
revealed by high-speed atomic force microscopy. elife 4, e04806 (2015).
44. Suloway, C. et al. Automated molecular microscopy: the new Leginon system.
J. Struct. Biol. 151, 41–60 (2005).
45. Kremer, J. R., Mastronarde, D. N. & McIntosh, J. R. Computer visualization of
three-dimensional image data using IMOD. J. Struct. Biol. 116, 71–76 (1996).
46. Schneider, C. A., Rasband, W. S. & Eliceiri, K. W. NIH Image to ImageJ: 25
years of image analysis. Nat. Methods 9, 671–675 (2012).
47. Rico, F., Gonzalez, L., Casuso, I., Puig-Vidal, M. & Scheuring, S. High-speed
force spectroscopy unfolds titin at the velocity of molecular dynamics
simulations. Science 342, 741–743 (2013).
48. Garcia, R. Amplitude modulation Atomic Force Microscopy (Wiley, 2010).
Acknowledgements
We thank Yousuke Furuta for providing us with T-705RTP; Yoshihiro Kawaoka for
providing us with plasmids; Ichiro Taniguchi, Keiko Shindo, Akiko Makino, and Keizo
Tomonaga for technical assistance; Akira Ishihama for helpful discussion; Toshio Ando
and Takayuki Uchihashi for technical support and valuable discussions at Bio-AFM
Summer School 2014 held at Kanazawa University. We also thank Editage (www.editage.
com) for English language editing. We thank Steven D. Aird for technical editing (www.
sda-technical-editor.org). This work was supported by a JSPS Grant-in-Aid for Scientific
Research (C) (16K08808, 19K07575) (to M.N.), a JSPS Grant-in-Aid for Early-Career
Scientists (19K16667), a Research Grant from the Kazato Research Encouragement Prize
(to Y.S.), an AMED Platform project for Supporting Drug Discovery and Life Science
Research (BINDS) (JP18am0101076) (to M.W.), a Japan Science and Technology Agency
PRESTO grant (JPMJPR13L9), a JSPS Grant-in-Aid for Scientific Research (B)
(17H04082, 20H03494), a JSPS Grant-in-Aid for Challenging Research (Exploratory)
(19K22529), JSPS Core-to-Core Program A, a MEXT Grant-in-Aid for Scientific
Research on Innovative Area (19H04831), an AMED Research Program on Emerging
and Re-emerging Infectious Disease grants (19fk0108113, 20fk0108270h0001), a Grant
from the Daiichi Sankyo Foundation of Life Science, and the Uehara Memorial Foun-
dation (to T.N.), and grants from the Joint Research Project of the Institute of Medical
Science, the University of Tokyo, the Joint Usage/Research Center program of Institute
for Frontier Life and Medical Sciences Kyoto University, and the Takeda Science
Foundation (to Y.S. and T.N.). M.W. was supported by direct funding from Okinawa
Institute of Science and Technology Graduate University.
Author contributions
M.N. and T.N. designed the study. M.N., Y.S., N.K., S.M. and Y.M. performed the
experiments. M.N., Y.S., N.K., S.M. and T.N. analysed data. M.N., Y.S., M.W. and T.N.
wrote the manuscript. All authors reviewed and approved the manuscript.
Competing interests
The authors declare no competing interests.
Additional information
Supplementary information The online version contains supplementary material
available at https://doi.org/10.1038/s42003-021-02388-4.
Correspondence and requests for materials should be addressed to T.N.
Peer review information Communications Biology thanks the anonymous reviewers for
their contribution to the peer review of this work. Primary Handling Editors: Anam
Akhtar. Peer reviewer reports are available.
Reprints and permission information is available at http://www.nature.com/reprints
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in
published maps and institutional affiliations.
Open Access This article is licensed under a Creative Commons
Attribution 4.0 International License, which permits use, sharing,
adaptation, distribution and reproduction in any medium or format, as long as you give
appropriate credit to the original author(s) and the source, provide a link to the Creative
Commons license, and indicate if changes were made. The images or other third party
material in this article are included in the article’s Creative Commons license, unless
indicated otherwise in a credit line to the material. If material is not included in the
article’s Creative Commons license and your intended use is not permitted by statutory
regulation or exceeds the permitted use, you will need to obtain permission directly from
the copyright holder. To view a copy of this license, visit http://creativecommons.org/
licenses/by/4.0/.
© The Author(s) 2021
ARTICLE COMMUNICATIONS BIOLOGY | https://doi.org/10.1038/s42003-021-02388-4
10 COMMUNICATIONS BIOLOGY |           (2021) 4:858 | https://doi.org/10.1038/s42003-021-02388-4 | www.nature.com/commsbio
